Richard C. Josiassen

Psychiatry Drexel University College of Medicine, Philadelphia, PA, United States 
Schizophrenia, neuroscience, neurophysiology
"Richard Josiassen"
Mean distance: 15.39 (cluster 20)
Cross-listing: PsychTree

BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Farrell M, Lichtenstein M, Crowley J, et al. (2019) THE GENOMICS OF HIGHLY TREATMENT RESISTANT SCHIZOPHRENIA European Neuropsychopharmacology. 29: S1006-S1007
Josiassen RC, Filmyer DM, Gillean J, et al. (2017) Successful Treatment of Severe Tardive Dyskinesia with Valbenazine, Including a Patient's Perspective. The American Journal of Case Reports. 18: 1185-1189
Kane J, Josiassen R, Burke J, et al. (2017) SA17. Response to Treatment With Valbenazine (NBI-98854) in Subjects With Tardive Dyskinesia Schizophrenia Bulletin. 43: S119-S119
Geboy AG, Filmyer DM, Josiassen RC. (2012) Motor deficits associated with mild, chronic hyponatremia: a factor analytic study. Journal of Motor Behavior. 44: 255-9
Josiassen RC, Curtis JL, Shaughnessy RA, et al. (2012) Vaptans: a potential new approach for treating chronic hyponatremia in psychotic patients. Clinical Schizophrenia & Related Psychoses. 6: 21-6
Josiassen RC, Filmyer DM, Geboy AG, et al. (2012) Psychomotor deficits associated with hyponatremia: a retrospective analysis. The Clinical Neuropsychologist. 26: 74-87
Josiassen RC, Shaughnessy RA, Filymer DM, et al. (2010) Early intervention with second-generation antipsychotics in first-episode psychosis: results of an 8-week naturalistic study. Early Intervention in Psychiatry. 4: 57-63
Josiassen RC, Curtis J, Filmyer DM, et al. (2010) Tolvaptan: a new tool for the effective treatment of hyponatremia in psychotic disorders. Expert Opinion On Pharmacotherapy. 11: 637-48
Josiassen RC, Filmyer DM, Curtis JL, et al. (2009) An archival, follow-forward exploration of the metabolic syndrome in randomly selected, clozapine-treated patients Clinical Schizophrenia and Related Psychoses. 3: 87-96
Josiassen RC, Goldman M, Jessani M, et al. (2008) Double-blind, placebo-controlled, multicenter trial of a vasopressin V2-receptor antagonist in patients with schizophrenia and hyponatremia. Biological Psychiatry. 64: 1097-100
See more...